Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 49884-484

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 49884-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine (Lamotrigine Tablet 1)

Chemical structure diagram of lamotrigine, showing its molecular framework with chlorine and amino substituents on a fused aromatic ring system.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 10)

Packaging label for Lamotrigine Orally Disintegrating Tablets Patient Titration Kit by Par Health USA, LLC. The kit contains 21 tablets of 25 mg strength and 7 tablets of 50 mg strength. Instructions detail the dosing schedule for weeks 1 to 4 and include a four-step guide on opening and taking the tablets. The label emphasizes use for patients taking valproate and includes a caution to verify product dispensed.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 11)

Packaging label for Lamotrigine Patient Titration Kit by Par Health USA, LLC, containing orally disintegrating tablets. The label details dosing instructions for weeks 3, 4, and 5, with 50 mg tablets for weeks 3 and 4 and 100 mg tablets for week 5. The label also includes step-by-step instructions for tablet administration and storage information. The label states the product is made in India and distributed by Par Pharmaceutical, Chestnut Ridge, NY.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 12)

Lamotrigine Patient Titration Kit packaging label for orally disintegrating tablets by Par Health USA, LLC. The kit contains 42 tablets of 50 mg and 14 tablets of 100 mg strength. Directions for weeks 1, 2, and 3 are detailed, including daily dosage instructions and steps for opening and administering the tablets. The packaging emphasizes careful reading of the accompanying medication guide.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 13)

Lamotrigine Patient Titration Kit carton for orally disintegrating tablets by Par Health USA, LLC. The label includes dosing instructions for weeks 1 & 2 with 25 mg tablets and weeks 3 & 4 with 50 mg tablets, plus a final dose of 100 mg tablets in week 5. The kit contains 14 tablets of 25 mg, 14 tablets of 50 mg, and 7 tablets of 100 mg. Instructions for use and handling are detailed on the packaging.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 14)

Packaging label for Lamotrigine Orally Disintegrating Tablets from Par Health USA, LLC, identified as a Patient Titration Kit. The label includes separate blister counts for Week 3 & 4 (50 mg tablets) and Week 5 (100 mg tablets), with illustrated instructions on tablet administration. The label displays storage instructions, manufacturer details, and a barcode on a predominantly orange and white background.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 2)

A Kaplan-Meier plot displaying failure probability percentages over weeks for Lamotrigine versus placebo. The graph shows curves for both treatment groups, with censored data points marked. The x-axis represents weeks, and the y-axis shows failure probability (%). The placebo curve reaches higher failure probabilities compared to Lamotrigine over the timeline.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 3)

A Kaplan-Meier curve chart showing failure probability (%) on the y-axis versus weeks on the x-axis, comparing Lamotrigine and placebo. The graph displays separate lines for 'Placebo' and 'Lamotrigine' over a period of up to approximately 75 weeks, with censored data points marked. The chart visually compares the time to failure between the two groups in a clinical study context.*

FDA Label Image

Lamotrigine-diagram.jpg (Lamotrigine Tablet 4)

An illustration showing the imprint details for Lamotrigine orally disintegrating tablets in various strengths: 25 mg white tablet imprinted with 'NT' on one side and '123' on the other; 50 mg white tablet imprinted with 'EP' on one side and '191' on the other; 100 mg peach tablet imprinted with 'E' on one side and '432' on the other; 200 mg white tablet imprinted with 'EP' on one side and '433' on the other.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 5)

Lamotrigine 25 mg orally disintegrating tablets maintenance pack carton by Par Health USA, LLC. The carton holds 30 unit-of-use tablets and is labeled for patients already taking lamotrigine, not for initial titration. Instructions for use and medication tips are printed on the packaging along with cautionary notes and barcode.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 6)

Lamotrigine 50 mg Maintenance Pack oral disintegrating tablets by Par Health USA, LLC, containing 30 unit-of-use tablets. The carton is labeled for patients already taking lamotrigine and not for initial titration. It includes instructions on how to take the medication and cautions to verify product dispensed.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 7)

Packaging label for Lamotrigine 100 mg orally disintegrating tablets, Maintenance Pack, containing 30 unit-of-use tablets. The label highlights that this pack is intended for patients already taking Lamotrigine and is not for initial titration. It includes patient tips for medicine adherence and step-by-step instructions for using the unit-of-use tablets. Labeler is Par Health USA, LLC.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 8)

Packaging label for Lamotrigine 200 mg orally disintegrating tablets, Maintenance Pack by Par Pharmaceutical. The carton contains 30 unit-of-use tablets, intended for patients already taking Lamotrigine and not for initial titration. The label includes usage instructions, a caution to verify dispensed product, and step-by-step directions for taking the tablets.*

FDA Label Image

Lamotrigine (Lamotrigine Tablet 9)

Lamotrigine Orally Disintegrating Tablets Patient Titration Kit packaging label by Par Health USA, LLC. The kit includes 21 tablets of 25 mg and 7 tablets of 50 mg strength. It provides instructions for weeks 1 to 4 dosing and tablet usage steps. Blue and yellow color scheme with detailed patient guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.